A prospective randomised trial of adjuvant chemotherapy in node positive early stage carcinoma of the cervix
Not Applicable
Completed
- Conditions
- CancerCervix cancerMalignant neoplasm of cervix uteri
- Registration Number
- ISRCTN52711596
- Lead Sponsor
- Cancer Research UK (CRUK) (UK)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Female
- Target Recruitment
- 0
Inclusion Criteria
1. Histologically proven invasive adeno or squamous cell carcinoma of the cervix
2. Histologically proven pelvic lymph node involvement
3. Stage Ib or IIa disease
4. Fit to receive either treatment arm
5. Adequate renal hepatic and haematological function
6. Adequate pulmonary function
7. Patients with a probability of <0.2 of not developing severe encephalopathy with ifosfamide/mensa treatment are excluded
8. No second primary tumour other than basal cell carcinoma of the skin
9. No other serious medical or psychological condition precluding treatment
Exclusion Criteria
Not provided at time of registration
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ot provided at time of registration
- Secondary Outcome Measures
Name Time Method ot provided at time of registration